Style | Citing Format |
---|---|
MLA | Hazrati A, et al.. "Crispr/Cas9-Engineered Mesenchymal Stromal/Stem Cells and Their Extracellular Vesicles: A New Approach to Overcoming Cell Therapy Limitations." Biomedicine and Pharmacotherapy, vol. 156, no. , 2022, pp. -. |
APA | Hazrati A, Malekpour K, Soudi S, Hashemi SM (2022). Crispr/Cas9-Engineered Mesenchymal Stromal/Stem Cells and Their Extracellular Vesicles: A New Approach to Overcoming Cell Therapy Limitations. Biomedicine and Pharmacotherapy, 156(), -. |
Chicago | Hazrati A, Malekpour K, Soudi S, Hashemi SM. "Crispr/Cas9-Engineered Mesenchymal Stromal/Stem Cells and Their Extracellular Vesicles: A New Approach to Overcoming Cell Therapy Limitations." Biomedicine and Pharmacotherapy 156, no. (2022): -. |
Harvard | Hazrati A et al. (2022) 'Crispr/Cas9-Engineered Mesenchymal Stromal/Stem Cells and Their Extracellular Vesicles: A New Approach to Overcoming Cell Therapy Limitations', Biomedicine and Pharmacotherapy, 156(), pp. -. |
Vancouver | Hazrati A, Malekpour K, Soudi S, Hashemi SM. Crispr/Cas9-Engineered Mesenchymal Stromal/Stem Cells and Their Extracellular Vesicles: A New Approach to Overcoming Cell Therapy Limitations. Biomedicine and Pharmacotherapy. 2022;156():-. |
BibTex | @article{ author = {Hazrati A and Malekpour K and Soudi S and Hashemi SM}, title = {Crispr/Cas9-Engineered Mesenchymal Stromal/Stem Cells and Their Extracellular Vesicles: A New Approach to Overcoming Cell Therapy Limitations}, journal = {Biomedicine and Pharmacotherapy}, volume = {156}, number = {}, pages = {-}, year = {2022} } |
RIS | TY - JOUR AU - Hazrati A AU - Malekpour K AU - Soudi S AU - Hashemi SM TI - Crispr/Cas9-Engineered Mesenchymal Stromal/Stem Cells and Their Extracellular Vesicles: A New Approach to Overcoming Cell Therapy Limitations JO - Biomedicine and Pharmacotherapy VL - 156 IS - SP - EP - PY - 2022 ER - |